TinyGemsBreaks Archive - Page 129 of 140

MondayAug 01, 2022 11:16 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Names Industry Veteran as New COO

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence across automotive and smart infrastructure markets. Han joined Cepton in 2016 and has served as both vice president and senior vice president of operations, where he has led product development, commercialization and operational excellence teams;…

MondayAug 01, 2022 11:03 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Opens New Automotive EV Development Center in California

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has opened a new 16,000-square-foot automotive development center; the center is located in the center of the technology corridor of Irvine, California, and near the Irvine Spectrum Center. According to the announcement, as the company sees continued growth, it is strategically dividing its automotive teams between the new Irvine location and the existing MULN facility in Monrovia. The Irvine Automotive Development Center will house Mullen’s engineering design and development, styling, program management, marketing and finance teams, with Monrovia being home base for the company’s battery, powertrain, thermal and infotainment teams.…

FridayJul 29, 2022 2:17 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Leveraging Strategic Developments to Bring Its FIVE EV Crossover to Market

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently reported the results of its solid-state polymer battery testing. According to a recent article that contains excerpts from a Benzinga Brief, “Testing results from BIC [Battery Innovation Center] show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested at 343.28 Ah at 4.2 volts, exceeding expectations, and is in line with test tolerance from previous EV Grid test results. The data supports solid-state polymer battery cell technology that, when scaled to the vehicle pack level and at a 150-kilowatt hour equivalent, can deliver over 600 miles…

FridayJul 29, 2022 1:30 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in Europe, the U.S. and Asia. “Golden Matrix’s GM-X system and newly launched GMX-Ag platform are a gold standard for the iGaming market, delivering access to 10,000+ games from over 25 leading providers. More than 635 unique casino operations use Golden Matrix’s platform to serve more than 7 million registered users. The company made its entrance into the lucrative European markets…

ThursdayJul 28, 2022 12:22 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads.…

ThursdayJul 28, 2022 10:55 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting at the 42nd annual Canaccord Genuity Growth Conference; the four-day event is scheduled for Aug. 8–11, 2022, in Boston. During the conference, Cybin CEO Doug Drysdale will present a fireside chat. Drysdale’s presentation is slated for Thursday, Aug. 11, 2022, at 3:30 p.m. ET. Interested individuals are invited to watch a live webcast of the event or an archived version of the event, available on the company’s investor relations page following the live presentation. To view the live presentation, visit https://ibn.fm/ghBjR To view…

WednesdayJul 27, 2022 1:28 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so. As such, this only emphasizes Flora’s value as a good investment,” a recent article reads. “While making the announcement, Luis Merchan, Flora’s chairman and CEO, noted: ‘Flora continues to move assertively to execute…

WednesdayJul 27, 2022 12:05 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Hypertension Study Completes Dosing with No Serious Adverse Events

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing with its DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been completed in its multi-week human clinical hypertension study HYPER-H21-4. According to the update, no serious adverse events have been reported as a result of the dosing. “We are extremely pleased that dosing has been completed on time in this multi-week clinical study without any serious adverse events having occurred,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “Demonstrating a noteworthy safety and tolerability profile relative to conventional anti-hypertensive medications is one of Lexaria’s major goals with this…

WednesdayJul 27, 2022 10:35 am

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Present at J.P. Morgan Auto Conference

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the J.P. Morgan Auto Conference. Cepton is scheduled to present at the event at 5:15 p.m. ET. on Wednesday, Aug. 10, 2022. Interested parties may visit https://ibn.fm/53L5r to register and view a live webcast of the presentation. The registration link, along with the company’s investor presentation, will also be published to Cepton’s Investor Relations page. To view the full press release, visit https://ibn.fm/p1Qax About Cepton Inc.…

TuesdayJul 26, 2022 3:11 pm

TinyGemsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) File Form S-4 Merger Registration and Joint Proxy Statement

Tingo (OTC: TMNA) and MICT (NASDAQ: MICT) today announced that they have filed a registration and joint proxy statement with the Securities and Exchange Commission (“SEC”) in connection with their anticipated merger. According to the update, the merger is expected to create a >$1.0 billion annualized revenue and highly profitable fintech and agri-fintech company serving the African and Asian markets with a global expansion strategy. The SEC will now review the submission and, following its review and the registration statement being declared effective, shareholders of each company will have the ability to approve the merger. Upon approval of stockholders and…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks